LAB21 Limited

52 articles about LAB21 Limited

• NOVACYT Announces Plans To Combine With LAB21 Limited In A Stock-For-Stock Transaction

  5/27/2014

• LAB21 Limited and IntegraGen, Inc. Partner to Develop New Colorectal Cancer Diagnostic

  2/22/2013

• Selah Genomics Inc. Announces Management Buy-out of Lab21 Inc

  1/8/2013

• LAB21 Limited Announces Sale of South Carolina Operations

  1/8/2013

• Becton, Dickinson and Company, LAB21 Limited Partner for Cancer Mutation Testing

  10/15/2012

• LAB21 Limited Among First to Offer FDA Approved Companion Diagnostic in the US

  7/12/2012

• Clydesdale Bank £5 Million Funding to Support LAB21 Limited International Growth

  7/9/2012

• LAB21 Limited Partners With Major Pharmaceutical Company to Develop New Companion Diagnostic Assay

  6/27/2012

• LAB21 Limited Secures European and USA Patents for HCV Drug Resistance Genotyping

  5/15/2012

• LAB21 Limited Unveils New Molecular Analysis Services at Greenville Site

  5/11/2012

• LAB21 Limited Partners With Top 10 IVD Player to Develop New Aspergillus Molecular Assay

  4/10/2012

• LAB21 Limited and ITOR Launch Clinical Genomics Center in USA

  3/6/2012

• LAB21 Limited Announces Appointment of Industry Expert Fraser Logue

  2/21/2012

• LAB21 Limited Launches New Lung Cancer Companion Diagnostic Service

  2/16/2012

• LAB21 Limited Acquires New Real Time PCR Technology

  1/24/2012

• LAB21 Limited Wins Biomedical Project of the Year Award

  11/29/2011

• LAB21 Limited Announces Positive Results for Aspergillus Detection in Critical Care and Haematology Patients

  11/9/2011

• LAB21 Limited Announces Positive Results for Aspergillus Detection in Critical Care and Haematology Patients

  11/9/2011

• LAB21 Limited Extends CPA Accreditation

  10/27/2011

• LAB21 Limited Contributes to Human Genetics Commission Report on Diagnostic Testing

  8/5/2011